News, Events, & Publications

KITE TO ACQUIRE TMUNITY THERAPEUTICS TO PURSUE NEXT GENERATION CAR T-CELL THERAPY ADVANCEMENTS IN CANCER

Date: Tuesday, December 20, 2022

Link: View the Press Release

Tmunity presented phase 1 translational data from PSMA armored CAR T (TmPSMA-01 program) at SITC meeting

Date: Tuesday, November 8, 2022

Web Link: https://jitc.bmj.com/content/10/Suppl_2/A353

Tmunity presented pre-clinical data from the next gen double armored CAR T (TmPSMA-02 program), at ASCO GU meeting

Date: Thursday, February 17, 2022

Web Link: https://ascopubs.org/doi/abs/10.1200/JCO.2022.40.6_suppl.158

Tmunity presented data from the phase I study with first in class TnMUC1 targeted CAR T (TmTnMUC1-01) at ASCO 2021 meeting

Date: Thursday, May 19, 2021

Web Link: https://meetings.asco.org/abstracts-presentations/200445

None

Greig Communications: Kathy@greigcommunications.com